In summary, IFNγ pre-activation up-regulated the expression of several anti-inflammatory factors in mMSCs that were not found in EVs, suggesting that other factors might be related to the improvement of SSc markers in the lungs. This evidence concerns the gene IFNG and systemic sclerosis.